{{Rsnum
|rsid=10496702
|Gene=NCKAP5
|Chromosome=2
|position=133247997
|Orientation=plus
|GMAF=0.1882
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=NCKAP5
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 1.8 | 19.5 | 78.8
| HCB | 2.9 | 24.1 | 73.0
| JPT | 0.9 | 23.2 | 75.9
| YRI | 8.8 | 44.2 | 46.9
| ASW | 19.3 | 35.1 | 45.6
| CHB | 2.9 | 24.1 | 73.0
| CHD | 3.7 | 22.0 | 74.3
| GIH | 1.0 | 26.7 | 72.3
| LWK | 8.3 | 50.5 | 41.3
| MEX | 8.6 | 22.4 | 69.0
| MKK | 2.6 | 28.2 | 69.2
| TSI | 0.0 | 23.5 | 76.5
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=20889312
|Trait=None
|Title=A genome-wide meta-analysis identifies novel loci associated with schizophrenia and bipolar disorder
|RiskAllele=G
|Pval=7E-7
|OR=1.39
|ORtxt=[NR]
}}

{{PMID Auto
|PMID=17903299
|Title=A genome-wide association study for blood lipid phenotypes in the Framingham Heart Study.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}